Status:
COMPLETED
Developing a Risk Assessment System of Multidrug-resistant Organisms Infection
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Bacterial Infections
Eligibility:
All Genders
18+ years
Brief Summary
1. A retrospective analysis was performed to determine the prevalence of multidrug- resistant organisms infection in ICU from October 2017 to October 2019. 2. Non-MDRO patients were selected by random...
Eligibility Criteria
Inclusion
- Inclusion Criteria：
- Duration of ICU admission ≥ 48h
- no less than 18 years old
- Exclusion Criteria:
- Patients with MDRO infection at the time of admission
- Lack of case data
- MDRO colonized patients
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
917 Patients enrolled
Trial Details
Trial ID
NCT04688216
Start Date
January 1 2020
End Date
December 30 2022
Last Update
May 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009